-
The Million Women Study reported a small increase in the incidence of ovarian cancer and ovarian cancer mortality in current users of postmenopausal hormone therapy.
-
Human Papilloma Virus (HPV) is recognized worldwide as the principal culprit in the development of cervix cancer and its precursor dysplastic lesions. Also increasingly recognized is its role in other anogenital disease such as vulvar, vaginal and perianal warts, dysplasia and cancer.
-
In the May issue of the American Journal of Obstetrics and Gynecology, there was a report of a small randomized trial that might generate some cautious optimism regarding the treatment of PTL.
-
Dietary Intervention for Fatty Liver Disease: Fat or Carbohydrate Restriction?; Motivational Interviewing to Enhance Weight Control in Diabetic Women; One-stop Shopping for Osteoporosis Treatment; Post-stroke prevention of venous thromboembolism; Chronic Kidney Disease: Treatment Modality and Quality of Life; Hepatitis C and Risk for Lymphoma
-
The primary care physician is often asked to deal with foot pain. This issue covers many of the common chronic and acute conditions that plague patients and provides differential diagnoses and therapeutic approaches.
-
-
Sweeping new changes have been made to the guidelines for prevention of endocarditis in patients undergoing dental procedures.
-
Clinicians now have a dedicated continuous use oral contraceptive. The Food and Drug Administration (FDA) has given final approval to Lybrel from Wyeth Pharmaceuticals of Collegeville, PA. The drug represents the first combination contraceptive pill designed to be taken 365 days a year, without a placebo phase or pill-free interval.
-
In 1997, federal block grant funding for abstinence-only sexuality education went into effect. Despite limited research on the efficacy of such programs, many states applied for a portion of the $50 million in federal dollars.
-
The next patient in your exam room is a young female adolescent. How can you help motivate her when it comes to condom use?
